BioHeal AI
Tokyo, Japan· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $75M
Overview
An AI-driven drug discovery platform company targeting oncology and immunology.
OncologyImmunology
Technology Platform
A proprietary AI and machine learning platform that integrates multi-omics data to predict novel drug targets and design optimized therapeutic molecules.
Funding History
1Total raised:$75M
Follow-on Offering$75M
Opportunities
Potential to form lucrative partnerships with large pharma companies seeking to augment their R&D pipelines.
Risk Factors
Risk of platform validation failure if its AI-generated candidates do not show efficacy in biological assays and early clinical trials.
Competitive Landscape
Faces intense competition from well-funded global AI-biotech players like Recursion, Exscientia, and Insilico Medicine.